Ken Herrmann

704 posts

Ken Herrmann

Ken Herrmann

@ProfKHerrmann

Nuc Med - Theranostics - Innovation. Embracing Change.

Katılım Nisan 2022
301 Takip Edilen1.3K Takipçiler
Ken Herrmann retweetledi
Toni Choueiri, MD
Toni Choueiri, MD@DrChoueiri·
The⚽️tournament @ASCO is back: Registration is open--see below with @cdanicas for all what you need to know! #ASCO25 @OncoAlert @FAndreMD @jrgralow
Daniel Castellano@cdanicas

🎯🔥⚽️the most funky, friendly, fashioned social event is coming again!! 💪💪 @ASCO @ASCOPres 🚀 The World #ASCO26 football Cup! @DrChoueiri @FAndreMD 📆 Saturday May 30th (6.00-10.00PM) Registration is open Contact: cdanicas@gmail.com 🙌🙌Brasil, Argentina, Colombia,Peru and USA are confirmed🏃‍♂️🏃‍♂️ The latest versions were a lot of fun. 😎 Don't miss it and sign up!🔥 With a rock stars @DrChoueiri !! @OncoAlert @aaoncoclinica @SoaresAndrey @myESMO @raymanneh @GuardConsortium @DrFelixGuerrero

English
0
8
27
3.3K
Ken Herrmann retweetledi
Weijun Wei
Weijun Wei@Weijun_Wei89·
Seeing is believing. CcRCC has the most complex metastatic patterns and many patients are misdiagnosed in routine clinical practice. CD70 PET is changing the landscape in China, many patients benefit from the imaging clinical trials. Need to develop CD70 therapeutic drugs!
Elizabeth McKenna@ElizSMcKenna

Now online in @CD_AACR: [18F]RCCB6 PET/CT in Diagnosing Clear Cell Renal Cell Carcinomas: A Prospective Comparison Study with [18F]FDG PET/CT and Conventional Imaging - by Qianyun Wu, Shuxian An, @ArturoChiti, Gang Huang, Jianjun Liu, @Weijun_Wei89, and colleagues

English
0
3
8
912
Ken Herrmann retweetledi
OncoAlert
OncoAlert@OncoAlert·
As if we needed another reason to go to #APCCC26 and #IPCS26 🇨🇭 A warm welcome to the #APCCC5k , a great way to start the day with a fun Run/Walk around Lake Lugano Switzerland. More details once you get to Lugano, but just reminding our colleagues...Bring your Running shoes, we will :-) See you There!! @Silke_Gillessen & @AOmlin @fabioturco92 @Prof_IanD @drjefstathiou @Prof_Nick_James @ChrisSweens1 @BertrandTOMBAL @ZilliThomas @neerajaiims @bjartell @PBlanchardMD @BourlonMaite @Albert0Briganti @cdanicas @Ecastromarcos @mdesantis234 @nachoduranm @drlouiseemmett @stefanofanti4 @fontev1 @Nicola_Fossati @marty_gleave @ProfKHerrmann @DrMHofman @BarbaraJereczek @ravikanesvaran @FacsRaja @LoebStacy @quimmateo @DrRanaMcKay @amerseburger @CaPsurvivorship @declangmurphy @DrPaulNguyen @WilliamOhMD @piet_ost @DrSpratticus @cnsternberg @DrYukselUrun @UrsulaVogl Ping @nataliagandur @OncoAlert 🚨
English
16
15
32
6.4K
Ken Herrmann retweetledi
OncoAlert
OncoAlert@OncoAlert·
A reminder that #APCCC26 🇨🇭is coming in Late April and is OPEN TO EVERYONE, not just the Panel members and 👉️ REGISTER HERE: buff.ly/XpCWPdR 🚨 Enjoy 20% off when registering for both APCCC & IPCS 2026 Awarm invite to the Advanced Prostate Cancer Consensus Conference #APCCC26 in Lugano🇨🇭 Event Details: 📍 Palazzo Congressi, Lugano, Switzerland 🎟️ Register here 🎓 Credits requests: SGU – SSU, SSMO, SRO, SGMN In an era of rapid innovation and expanding treatment options for advanced #ProstateCancer , APCCC provides a vital forum for clinicians and researchers to address complex clinical questions where high-level evidence is limited. Over two days, the world’s leading experts will engage in high-level presentations, debates, and discussions to clarify and conceptualize the current landscape of care, with a focus on areas of controversy or uncertainty. The insights and consensus developed during the meeting are later published in European Urology, helping shape global standards. Creating new opportunities for younger investigators & the next generation of leaders in advanced prostate cancer! @Silke_Gillessen & @AOmlin @fabioturco92 @Prof_IanD @drjefstathiou @Prof_Nick_James @ChrisSweens1 @BertrandTOMBAL @ZilliThomas @neerajaiims @bjartell @PBlanchardMD @BourlonMaite @Albert0Briganti @cdanicas @Ecastromarcos @mdesantis234 @nachoduranm @drlouiseemmett @stefanofanti4 @fontev1 @Nicola_Fossati @marty_gleave @ProfKHerrmann @DrMHofman @BarbaraJereczek @ravikanesvaran @FacsRaja @LoebStacy @quimmateo @DrRanaMcKay @amerseburger @CaPsurvivorship @declangmurphy @DrPaulNguyen @WilliamOhMD @piet_ost @DrSpratticus @cnsternberg @DrYukselUrun Ping @nataliagandur @OncoAlert 🚨
English
0
5
16
976
Ken Herrmann retweetledi
Michael Hofman
Michael Hofman@DrMHofman·
PCWG4 is launched: ascopubs.org/doi/10.1200/JC… Imaging response is expanded to include PSMA PET/CT. In the future, patient may have 1 scan (PSMA PET with CT) rather than two scans (CT+ bone scan). All my nuclear colleagues will be happy to retire the bone scan. @AarmstrongDuke
Michael Hofman tweet media
Andrea Necchi@AndreaNecchi

Congratulations to the PCWG4 panel! #GU26 @JCO_ASCO @ASCO @AarmstrongDuke @DrRanaMcKay @morris @DrScottTagawa and many more ascopubs.org/doi/pdfdirect/…

English
2
16
44
3.7K
Ken Herrmann retweetledi
OncoAlert
OncoAlert@OncoAlert·
The #OncoAlertTopTweet 🚨DAY ONE #GU26 Post: OncoAlert Just Published at @JCO_ASCO and out for #GU26 ABSTRACT 162 Poster Bd E17 Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4 👉ascopubs.org/doi/10.1200/JC… Here is Dr Michael Morris🇺🇸from @MSKCancerCenter to tell us more #ProstateCancer @montypal @crisbergerot @DrDanielHeng @apolo_andrea @DrChoueiri @PGrivasMDPhD @TiansterZhang @HHammersMD @ravikanesvaran @neerajaiims @amerseburger @sonpavde @drenriquegrande @scserendipity1 @Silke_Gillessen @EfstathiouEleni @tompowles1 @BraunMDPhD @nataliagandur @cdanicas @brian_rini @AOmlin @DrRanaMcKay Michael J. Morris @EAntonarakis @mishabeltran @drlouiseemmett @ProfKHerrmann @DrMHofman @JoshLangMD @CaPsurvivorship @Cpaller @cnsternberg
OncoAlert@OncoAlert

Just Published at @JCO_ASCO and out for #GU26 POSTER NOW BEING PRESENTED 11:30-12:45pm ABSTRACT 162 Poster Bd E17 (Please Visit) Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4 👉ascopubs.org/doi/10.1200/JC… Here is Dr Michael Morris🇺🇸from @MSKCancerCenter to tell us more #ProstateCancer @DrRanaMcKay Michael J. Morris @EAntonarakis @AarmstrongDuke @mishabeltran @drlouiseemmett @ProfKHerrmann @DrMHofman @JoshLangMD @CaPsurvivorship @Cpaller @cnsternberg

English
0
6
13
754
Ken Herrmann retweetledi
OncoAlert
OncoAlert@OncoAlert·
The #OncoAlertTopTweet 🚨DAY ONE #GU26 Post: OncoAlert 🌐 Just Published at @JCO_ASCO and out for #GU26 Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4 👉ascopubs.org/doi/10.1200/JC… Here is Dr Andrew Armstrong🇺🇸 @AarmstrongDuke to tell us more #ProstateCancer @montypal @crisbergerot @DrDanielHeng @apolo_andrea @DrChoueiri @PGrivasMDPhD @TiansterZhang @HHammersMD @ravikanesvaran @neerajaiims @amerseburger @sonpavde @drenriquegrande @scserendipity1 @Silke_Gillessen @EfstathiouEleni @tompowles1 @BraunMDPhD @nataliagandur @cdanicas @brian_rini @AOmlin @DrRanaMcKay Michael J. Morris @EAntonarakis @mishabeltran @drlouiseemmett @ProfKHerrmann @DrMHofman @JoshLangMD @CaPsurvivorship @Cpaller @cnsternberg
OncoAlert@OncoAlert

Just Published at @JCO_ASCO and out for #GU26 Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4 ascopubs.org/doi/10.1200/JC… Here is Dr Andrew Armstrong🇺🇸 @AarmstrongDuke to tell us more #ProstateCancer @DrRanaMcKay Michael J. Morris @EAntonarakis @mishabeltran @drlouiseemmett @ProfKHerrmann @DrMHofman @JoshLangMD @CaPsurvivorship @Cpaller @cnsternberg

English
0
6
14
684
Ken Herrmann retweetledi
OncoAlert
OncoAlert@OncoAlert·
The #OncoAlertTopTweet 🚨DAY ONE #GU26 #APCCC26 🇨🇭 is open to everyone (not just panel members!) and is on April 30-May 2nd in Lugano EARLY REGISTRATION CLOSES February 28, 2026 👉 REGISTER HERE: buff.ly/XpCWPdR Join global experts in advanced #ProstateCancer at the Advanced Prostate Cancer Consensus Conference in Lugano (Palazzo Congressi) for two days of high-level debates addressing real-world clinical questions where evidence is limited, shaping future standards of care published in European Urology while creating opportunities for the next generation of leaders; enjoy 20% off when registering for both APCCC & IPCS 2026 @Silke_Gillessen @AOmlin @fabioturco92 @Prof_IanD @drjefstathiou @Prof_Nick_James @ChrisSweens1 @BertrandTOMBAL @ZilliThomas @neerajaiims @bjartell @PBlanchardMD @BourlonMaite @Albert0Briganti @cdanicas @Ecastromarcos @mdesantis234 @nachoduranm @drlouiseemmett @stefanofanti4 @fontev1 @Nicola_Fossati @marty_gleave @ProfKHerrmann @DrMHofman @BarbaraJereczek @ravikanesvaran @FacsRaja @LoebStacy @quimmateo @DrRanaMcKay @amerseburger @CaPsurvivorship @declangmurphy @DrPaulNguyen @WilliamOhMD @piet_ost @DrSpratticus @cnsternberg @DrYukselUrunPing @nataliagandur @OncoAlert
OncoAlert@OncoAlert

Colleagues at #GU26 ,A reminder that #APCCC26 🇨🇭is coming in 2026 This is a Conference is OPEN TO EVERYONE, not just the Panel members and EARLY REGISTRATION is up until February 28, 2026 👉️ REGISTER HERE: buff.ly/XpCWPdR Only 🔟 days left until the Early Bird deadline (28 February 2026) Enjoy 20% off when registering for both APCCC & IPCS 2026 Awarm invite to the Advanced Prostate Cancer Consensus Conference #APCCC26 in Lugano🇨🇭 Event Details: 📍 Palazzo Congressi, Lugano, Switzerland 🎟️ Register here 🎓 Credits requests: SGU – SSU, SSMO, SRO, SGMN In an era of rapid innovation and expanding treatment options for advanced #ProstateCancer , APCCC provides a vital forum for clinicians and researchers to address complex clinical questions where high-level evidence is limited. Over two days, the world’s leading experts will engage in high-level presentations, debates, and discussions to clarify and conceptualize the current landscape of care, with a focus on areas of controversy or uncertainty. The insights and consensus developed during the meeting are later published in European Urology, helping shape global standards. Creating new opportunities for younger investigators & the next generation of leaders in advanced prostate cancer! @Silke_Gillessen & @AOmlin @fabioturco92 @Prof_IanD @drjefstathiou @Prof_Nick_James @ChrisSweens1 @BertrandTOMBAL @ZilliThomas @neerajaiims @bjartell @PBlanchardMD @BourlonMaite @Albert0Briganti @cdanicas @Ecastromarcos @mdesantis234 @nachoduranm @drlouiseemmett @stefanofanti4 @fontev1 @Nicola_Fossati @marty_gleave @ProfKHerrmann @DrMHofman @BarbaraJereczek @ravikanesvaran @FacsRaja @LoebStacy @quimmateo @DrRanaMcKay @amerseburger @CaPsurvivorship @declangmurphy @DrPaulNguyen @WilliamOhMD @piet_ost @DrSpratticus @cnsternberg @DrYukselUrun Ping @nataliagandur @OncoAlert 🚨

English
0
12
17
1.8K
Ken Herrmann retweetledi
Advanced Prostate Cancer Consensus Conference
Advanced Prostate Cancer Consensus Conference@APCCC_Lugano·
177Lu-PSMA-617 Monotherapy Is Provocative but No Standard of Care for Metastatic Hormone-Sensitive Prostate Cancer jnm.snmjournals.org/content/66/11/… This invited perspective discusses a patient with low-volume metastatic hormone-sensitive #ProstateCancer who declined standard ADT-based therapies and instead received first-line off-label Lu-PSMA monotherapy, achieving a partial response with minimal toxicity. Although the case is intriguing and reflects growing interest in earlier PSMA-targeted treatment, the authors stress that it represents a single, highly selected patient and does not outweigh strong evidence supporting ADT-based doublet or triplet regimens as the proven standard of care. They highlight key limitations—modest PSA response, short follow-up, uncertain generalizability, mechanistic uncertainties, and ethical concerns about off-label use—and emphasize that Lu-PSMA monotherapy should not be used outside clinical trials. Overall, while patients may wish to avoid ADT side effects, there is no evidence that ADT-free strategies preserve survival, and prospective studies are essential before altering current practice. @ProfHadaschik @Silke_Gillessen Oliver Sartor @OncoAlert 🚨 @AOmlin @weoncologists
Advanced Prostate Cancer Consensus Conference tweet media
English
1
14
29
2.8K
Ken Herrmann retweetledi
Michael Hofman
Michael Hofman@DrMHofman·
First in the world @GEHealthCare Omni 128cm Total Body PET just installed at @PeterMacCC ... serial number 001. 50 times the sensitivity of our existing PET scanner enabling faster scanning with less radiation and greater clarity. Our new centre seamlessly integrates pre-clinical imaging, state-of-the-art radiopharmaceutical sciences to enable rapid translation from laboratory to clinic. Thank-you to @ACRF_ @NIFAus @UniMelb
Michael Hofman tweet media
Peter Mac Cancer Centre@PeterMacCC

A major step forward for precision medicine today. Peter Mac has installed cutting-edge @GEHealthCare total body PET/CT technology — supported by $15M in new grants and funding.

English
1
6
44
6K
Ken Herrmann retweetledi
Medthority
Medthority@Medthority·
PSMA PET scans are packed with potential, but making sense of all that data? That’s where automation steps in. @ProfKHerrmann shares insights on how PSMA-TTV could unlock new levels of precision in patient selection for radioligand therapy🔓 #ESMO25 #ProstateCancer #MedX
English
0
2
3
211
Ken Herrmann retweetledi
Advanced Prostate Cancer Consensus Conference
Advanced Prostate Cancer Consensus Conference@APCCC_Lugano·
A warm invite to all, we wait for you at #APCCC26 ⭐ Full details & submission apccc.org @Silke_Gillessen & @AOmlin @OncoAlert 🚨 @fabioturco92 @Prof_IanD @drjefstathiou @Prof_Nick_James @ChrisSweens1 @BertrandTOMBAL @ZilliThomas @neerajaiims @bjartell @PBlanchardMD @BourlonMaite @Albert0Briganti @cdanicas @Ecastromarcos @mdesantis234 @nachoduranm @drlouiseemmett @stefanofanti4 @fontev1 @Nicola_Fossati @marty_gleave @ProfKHerrmann @DrMHofman @BarbaraJereczek @ravikanesvaran @FacsRaja @LoebStacy @quimmateo @DrRanaMcKay @amerseburger @CaPsurvivorship @declangmurphy @DrPaulNguyen @WilliamOhMD @piet_ost @DrSpratticus @cnsternberg @DrYukselUrun @DrChoueiri @tompowles1 @brian_rini
OncoAlert@OncoAlert

Dear Colleagues at #ESMO25 An honor to present our faculty🚨 @Silke_Gillessen and @AOmlin straight from Berlin who discuss about: The Radioligand Therapy Session on #ProstateCancer VERY hot Topics and some that will spark up conversation in Lugano🇨🇭 for #APCCC26 @APCCC_Lugano @montypal @crisbergerot @DrDanielHeng @apolo_andrea @DrChoueiri @PGrivasMDPhD @TiansterZhang @HHammersMD @ravikanesvaran @neerajaiims @amerseburger @sonpavde @drenriquegrande @scserendipity1 @Silke_Gillessen @EfstathiouEleni @tompowles1 @BraunMDPhD @nataliagandur @cdanicas @bavilima @yekeduz_emre @DrYukselUrun @TylerSbrt @mgmglobal @LoebStacy @piet_ost @_ShankarSiva @seanmmcbride

English
0
14
27
5.8K

Keşfet

@ASCO @cdanicas @OncoAlert @FAndreMD @jrgralow @JournalofNucMed @PeterMacCC @declangmurphy